Certolizumab Inhibits Radiographic Progression Even in RA Patients with High Rheumatoid Factor Levels: A Pooled, Post-Hoc Analysis of Two Phase 3 Trials

被引：0
|
作者：
Smolen, Josef [1 ]
Burmester, Gerd [2 ]
Tanaka, Yoshiya [3 ]
Takeuchi, Tsutomu [4 ]
Curtis, Jeffrey [5 ]
Mikuls, Ted [6 ]
Lopez Medina, Clementina [7 ]
Taylor, Peter C. [8 ]
Tilt, Nicola [9 ]
Lauwerys, Bernard [10 ]
Ufuktepe, Baran [11 ]
Huizinga, Thomas [12 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany
[3] Univ Occupat & Environm Hlth, Dept Internal Med, Kitakyushu, Fukuoka, Japan
[4] Keio Univ, Dept Internal Med, Tokyo, Japan
[5] Univ Alabama Birmingham, Birmingham, AL USA
[6] Univ Nebraska Med Ctr, Omaha, NE USA
[7] Reina Sofia Univ Hosp, Cordoba, Spain
[8] Univ Oxford, Oxford, England
[9] UCB Pharma, Slough, England
[10] UCB Pharma, Brussels, Belgium
[11] UCB Pharma, Istanbul, Turkiye
[12] Leiden Univ, Dept Rheumatol, Leiden, Netherlands
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2286
引用
收藏
页码：4597 / 4600
页数：4
相关论文
共 50 条
  • [41] Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials
    Wenjia Chen
    Helen K. Reddel
    J Mark FitzGerald
    Richard Beasley
    Christer Janson
    Mohsen Sadatsafavi
    Respiratory Research, 24
  • [42] Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials
    Chen, Wenjia
    Reddel, Helen K.
    FitzGerald, J. Mark
    Beasley, Richard
    Janson, Christer
    Sadatsafavi, Mohsen
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [43] A Post Hoc Analysis of Immunoglobulin Levels in Patients with Relapsing Multiple Sclerosis Treated with Ozanimod in Phase 3 Trials
    Harris, S.
    Southworth, H.
    Sheffield, J. K.
    Maddux, R.
    Cohen, J.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 93 - 94
  • [44] Pain Reduction in Rheumatoid Arthritis Patients Who Use Opioids: A Post Hoc Analysis of Phase 3 Trials of Baricitinib
    Pope, Janet E.
    Lee, Yvonne C.
    Curtis, Jeffrey R.
    Mo, Daojun
    Xie, Li
    Dickson, Christina L.
    Schlichting, Douglas E.
    Cardoso, Anabela
    Simon, Lee S.
    Taylor, Peter C.
    ACR OPEN RHEUMATOLOGY, 2022, 4 (03) : 254 - 258
  • [45] Efficacy of cariprazine in the early stage of schizophrenia: a pooled, post-hoc analysis of 3 phase II/III double-blind placebo-controlled trials
    Dombi, Z. B.
    Acsai, K.
    Barabassy, A.
    Sebe, B.
    Laszlovszky, I.
    Vass, G.
    Szatmari, B.
    Patel, M.
    Earley, W.
    Nemeth, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S325 - S326
  • [46] EFFECTS OF SMOKING ON BARICITINIB EFFICACY IN PATIENTS WITH RHEUMATOID ARTHRITIS: POOLED ANALYSIS FROM TWO PHASE 3 CLINICAL TRIALS
    Curtis, J.
    Emery, P.
    Burmester, G.
    Arora, V.
    Alam, J.
    Muram, D.
    Klareskog, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 244 - 244
  • [47] Impact of Psoriasis Disease Activity and Other Risk Factors on Serum-urate Levels in Patients with Psoriasis and Psoriatic Arthritis - A Post-hoc Analysis of Pooled Data from Three Phase 3-trials with Secukinumab
    Dehlin, Mats
    Fasth, Andreas
    Reinhardt, Maximilian
    Jacobsson, Lennart
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [48] Efficacy and safety of fremanezumab in patients with migraine and obesity: post-hoc analysis of the phase 3 HALO-LTS and FOCUS clinical trials
    Irimia Sieira, P.
    Torphy, B.
    Ortega, M.
    Barash, S.
    Krasenbaum, L. J.
    Akcicek, H.
    Smith, M.
    Ning, X.
    Campos, V. Ramirez
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [49] PREDICTORS OF INADEQUATE RESPONSE AND RAPID RADIOGRAPHIC PROGRESSION IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS RECEIVING METHOTREXATE: A POST HOC ANALYSIS OF 2 RANDOMIZED, CONTROLLED TRIALS OF ADALIMUMAB
    Kavanaugh, A.
    van Vollenhoven, R. F.
    Wolfe, B. A.
    Florentinus, S.
    Chen, S.
    Suboticki, J. L.
    Smolen, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 822 - 823
  • [50] Predictors of Inadequate Response and Rapid Radiographic Progression in Patients with Early Rheumatoid Arthritis Receiving Methotrexate: a Post Hoc Analysis of 2 Randomized, Controlled Trials of Adalimumab
    Kavanaugh, Arthur
    van Vollenhoven, Ronald F.
    Wolfe, Benjamin A.
    Florentinus, Stefan
    Chen, Su
    Suboticki, Jessica L.
    Smolen, Josef S.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345